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Purpose. To analyze the diagnostic validity of accommodative and binocular tests in a sample of patients with a large near exophoria
withmoderate to severe symptoms.Methods. Two groups of patients between 19 and 35 years were recruited from a university clinic:
33 subjects with large exophoria at near vision and moderate or high visual discomfort and 33 patients with normal heterophoria
and low visual discomfort. Visual discomfort was defined using the Conlon survey. A refractive exam and an exhaustive evaluation
of accommodation and vergence were assessed. Diagnostic validity by means of receiver operator characteristic (ROC) curves,
sensitivity (S), specificity (Sp), and positive and negative likelihood ratios (LR+, LR−) were assessed. This analysis was also carried
out considering multiple tests as serial testing strategy. Results. ROC analysis showed the best diagnostic accuracy for receded near
point of convergence (NPC) recovery (area = 0.929) and binocular accommodative facility (BAF) (area = 0.886). Using the cut-offs
obtained with ROC analysis, the best diagnostic validity was obtained for the combination of NPC recovery and BAF (S = 0.77, Sp
= 1, LR+ = value tending to infinity, LR− = 0.23) and the combination of NPC break and recovery with BAF (S = 0.73, Sp = 1, LR+ =
tending to infinity, LR− = 0.27). Conclusions. NPC and BAF tests were the tests with the best diagnostic accuracy for subjects with
large near exophoria and moderate to severe symptoms.
1. Introduction
Convergence insufficiency (CI) is a sensory motor anomaly
that is characterized by an inability to accurately converge
or sustain convergence at near, which can cause substantial
symptomatology during reading and near visual tasks [1, 2].
It is a common vision anomaly usually characterized as a
binocular vision disorder with a low AC/A ratio in which the
patient may have an orthophoria or exophoria at distance,
with a moderate to high exophoria at near, greater than the
distance phoria [3, 4], reporting as clinical characteristics,
several symptoms and signs that can be present during the
visual examination [1, 5–10].
In recent years, several randomized clinical trials [11–
14] have studied the effectiveness of treatments for CI in
children and adults, showing that office-based vision therapy
with home reinforcement is the most effective treatment for
CI. In fact, several reviews have shown there is sufficient
evidence to support the use of vision therapy for CI [15–
18].
According to epidemiology, numerous studies have sug-
gested that this nonstrabismic binocular vision disorder
is commonly found in clinical practice [19–30]. However,
several authors have recently shown that the prevalence of
CI is not really known because no population-based studies
are available [31, 32]. Cacho-Mart´ınez et al. [32] have revealed
in a systematic review that there is a great variability in the
reported prevalence ofCI, ranging from2.25 to 33%.Thewide
discrepancies in prevalence figures obtained are due to both
sample population (neither randomized nor representative)
and the lack of uniformity in diagnostic criteria. Similarly,
Cooper and Jamal [31] have also shown in a recent literature
review that prevalence of CI has a great variability with the
average prevalence reported to be approximately 5%. They
state that this variability can be attributed to differences in the
definitions of CI, the sample studied (clinic samples versus
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general population), and differences in testing protocols.
Other studies have also shown that patients with traumatic
brain injury (TBI) have a greater incidence rate [33]. CI is
evident in up to 48%of veterans exposed to blast injuries [34–
36] and in about 40% of the civilian population with TBI,
predominantly from motor vehicle accidents and falls [37–
39].
Throughout the years, numerous investigators have used
diverse definitions in the diagnosis of CI [31] existing different
clinical criteria for diagnosing this condition [1, 5–10]. In fact,
when studying this anomaly there is not a particular clinical
signwhichmay assure that a patient has CI so that, in general,
clinicians use a battery of symptoms and signs which allow
them its diagnosis.
Symptoms are varied, usually associated with tasks at
near vision [4] including asthenopia, headaches, eyestrain,
intermittent blurred vision, intermittent diplopia, impossi-
bility to maintain clear vision for a reasonable period of
time, difficulty in reading,movement of letters, sleepingwhen
reading, decreasing the comprehension of reading with time,
and loss of concentration [1, 17, 22, 40–42]. These symptoms
may negatively impact an individual’s quality of life and daily
activities such as employment [38] and schoolwork [43].
The association of CI and symptoms has been investigated
by the Convergence Insufficiency Treatment Trial Study
Group (CITT Study Group) who developed the Convergence
Insufficiency Symptom Survey (CISS) [6–8]. It is a question-
naire with 15 questions designed to quantify the severity of
symptoms associated with CI. Initial [6–8] and later studies
[44] have confirmed the validity and reliability of the CISS
V-15 for evaluating symptoms in adults and children with CI.
Similarly, Conlon et al. [45] developed a survey to measure
visual discomfort in adults. The survey, which consists of 23
items, has been shown to be a valid instrument to measure
visual anomalies reported by subjects with visual discomfort
[45, 46]. Borsting et al. [47] have also revealed that both the
Conlon et al. survey [45] and the CISS V-15 [7, 8] are reliable
to investigate the long-term variability of visual discomfort.
They encountered that visual discomfort symptom reporting
using the Conlon survey is stable in the majority of college
students over a 1-year period, reporting a good intraclass
correlation coefficient (0.82).
Several authors [1, 4–10] refer to different clinical signs
during visual examination: a moderate or high exophoria
at near (greater than at distance vision), reduced positive
fusional vergence (PFV) at near, reduced vergence facil-
ity at near with base-out prisms, a receded near point
of convergence (NPC), a binocular accommodative facility
(BAF) reduced with +2.00D, diminished MEM retinoscopy
or low fused crossed cylinders, diminished negative rela-
tive accommodation (NRA), exofixation disparity at near
vision, intermittent suppression at near vision, and even a
limited stereopsis. Recently, a systematic review [48] about
the evidence of diagnostic criteria for general binocular
dysfunctions has shown the use of different number of clinical
signs [1, 5–10] ranging from one to five tests. Although no one
of the authors validates the tests used by comparison against
an established reference standard (gold standard) [49], all
of them agree to consider the large exophoria at near for
diagnosing CI, being both the PFV (85.7%) and the receded
NPC (71.4%) the other clinical tests most frequently used
[48].
In this sense, the CITT group developed a classification
scheme for CI based on the following signs: exophoria at
near vision greater than distance, ≥4 prismatic diopters (Δ),
recededNPC, and reduced PFV range [28].This classification
system, as the authors declare in their study, is based on the
signs most often associated with CI and many investigators
have used it for prevalence, diagnosis and treatment purposes
[1, 6–8, 11–14, 18, 22, 28, 29, 40, 41, 44].
In addition to the great variety of clinical signs for CI,
scientific literature [48] also shows differences on cut-offs
points for different tests. The large near exophoria varies
between authors from 5Δ [1, 6–8], >6Δ [9] to 16Δ [10].
Similarly, some investigators consider receded NPC, values
those results for break NPC which are ≥6 cm [1, 7, 8], ≥7.5 cm
[6] and >10/17.5 cm for break and recovery NPC, respectively
[9]. According to PFV,most authors [1, 6–8] consider reduced
PFV at near when patient fails to reach Sheard’s criteria [4]
or fails to have minimum normative at near (≤15Δ) for break.
Others [9] consider a reduced value of PFV≤ 11/14/3Δ or PFV
= 0Δ [5].
Consequently, disparity of both clinical signs and cut-
offs may provide unequal diagnoses among authors. In any
case, the greater difficulty of existing studies about diagnosis
of CI are the lack of epidemiological criteria to justify the
use of several tests as well as their cut-offs. They do not
analyze diagnostic validity of clinical signs using likelihood
ratios, sensitivity, specificity, or receiver operator characteris-
tic (ROC) curves. The authors diagnose based on the criteria
they consider patients should have without justifying why
certain clinical signs must be taken into account and others
must not.
Considering that CI is a nonstrabismic binocular
anomaly associated with a large near exophoria [4], the
aim of this study is to identify the accommodative and
binocular tests which present anomalous values in a sample
of patients with a large near exophoria with moderate to
severe symptoms and to analyze their diagnostic validity by
means of ROC analysis, sensitivity, specificity, and likelihood
ratios.
2. Material and Methods
2.1. Patients. A prospective study was conducted at the
Optometric Clinic of University of Alicante, Spain. For those
patients who were coming consecutively for a routine visual
examination with ages between 18 and 35, binocular status
was obtained using the cover test method. The upper limit
of 35 years was to avoid including subjects with prepresby-
opia [50]. The study followed the tenets of the Declaration
of Helsinki, and informed consent was obtained from all
subjects after explanation of the nature of the study.
One experienced author (PCM) served as examiner to
assess the cover testmethod for distance (6m) andnear vision
(40 cm). The subject’s subjective refraction was placed in a
trial frame. Once evaluated the cover-uncover test to rule out
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patients with tropias at distance or near vision; the alternate
cover test (ACT) protocol was then performed to evaluate
the heterophoria status [51–56]. For objective procedure of
prism neutralized ACT, each subject was instructed to fixate
on a single letter of 20/30 visual acuity. Using a prism bar the
phoria value was midway between the low and high neutral
findings using an ACT.
Following the ACT, other examiner measured visual
discomfort with Conlon et al. survey [45–47]. As we wanted
to analyze a sample of patientswith a large near exophoria and
visual symptomatology but initially they did not have the CI
diagnosis, a more general questionnaire than CISS V-15 one
was used. Conlon survey consists of 23 items related to near
tasks, asking the patient questions about the feeling of their
eyes when reading or the presence of several symptoms as
headache, diplopia, losing the placewhen reading,movement
of letters, difficulty reading the words on a page, and having
glare. Each item has a 4 point scale: 0: event never occurs,
1: occasionally, a couple of times a year, 2: Often, every few
weeks, and 3: almost always, yielding scores ranging from 0 to
69.Once the patient has answered all items, the survey defines
the following groups: low discomfort group (scored from 0 to
24), moderate discomfort group (scored from 25 to 48), and
high visual discomfort (scored from 49 to 69).
Taking into account ACT results and Conlon et al. scores
[45], consecutive patients were divided into two groups:
patients with large exophoria at near and moderate or high
visual discomfort (EXO-MHVD) and patients with normal
heterophoria and low visual discomfort (NH-LVD). The
inclusion criteria for both groups of subjects are explained in
Table 1. Following the inclusion criteria, 33 subjects with large
exophoria [4, 57, 58] and moderate to high visual discomfort
at near were selected. Their ages were ranging between 19
and 33 years, with a mean age of 24.76 ± 4.05 years. The
sample population of the normal heterophoria and low visual
discomfort group enrolled 33 persons with ages between 19
and 34 years with a mean age of 24.91 ± 3.95 years.
Each subject of both groups received an exhaustive
evaluation of accommodation and vergence. A battery of
accommodative and binocular tests which determine the
accommodative and vergence status of a patient were carried
out while the subjects wore their subjective refractive exam
in place. The following tests were performed. Monocular
accommodative amplitude (AA) with push-up method [59,
60]. Monocular and binocular accommodative facility (MAF,
BAF) was conducted following the procedure of Zellers et
al. [61] at 40 cm using ±2.00D flip lenses and a target
with suppression control, evaluating if patient had diffi-
culty focusing with plus or minus lenses. MEM dynamic
retinoscopy at 40 cm with the result of the subjective exam
placed in a trial frame and using trial lenses [62]. Positive
and negative relative accommodations (PRA, NRA) while
patient was fixating the horizontal line of 20/30 letters at
40 cm [63]. Positive fusional vergence at 40 cm with Risley
prism (with a smooth gradual increase in prism power) using
an accommodative target of 20/30 visual acuity [64] (VA).
Break and recovery near point of convergence (NPC) using
an accommodative target of 20/30VA [65] at 40 cm while
the subject was encouraged to try to keep the target single.
Table 1: Inclusion criteria for EXO-MHVD and NH-LVD groups.
EXO-MHVD group NH-LVD group
A score of 24 or higher on
Conlon survey [45] was
considered as moderate to severe
symptoms
A score lower than 24 on
Conlon survey [45] was
considered as low
symptoms
Near exophoria >6Δ. As the
expected value of near phoria
[4, 57, 58] is between a range of
ortophoria and 6Δ of exophoria,
this limit was selected to consider
having a large value of near
exophoria
Normative values for
distance and near phoria
[4, 57, 58]
Normative values of distance
phoria [57, 58], or having a
difference between both distance
and near phoria out of a range of
5Δ [4]
Far and near visual acuity
≥20/20 with the best
prescription, without
ocular motility disorders,
vertical deviation,
strabismus or ocular
pathology
Far and near visual acuity ≥20/20
with the best prescription,
without ocular motility
disorders, vertical deviation,
strabismus or any type of ocular
pathology
Distance was calculated from the midsagittal plane of the
patient’s head to the nearest half centimeter. Vergence facility
at 40 cm using loose prisms of 12Δ-base-out and 3Δ-base-in
at 40 cm while fixating an accommodative target of 20/30VA
[66]. Gradient AC/A ratio using cover test and −1.00D lenses
[4]. Due to the importance of controlling accommodation
during AC/A testing (as the accommodative response cannot
be known) the patient was asked to maintain clarity of the
test. Fusion with worth test and stereopsis with graded circles
of Randot SO-002 test [4].
2.2. Epidemiology and Statistics. With the results of accom-
modative and binocular tests of both groups the Mann-
Whitney U test for two independent samples was performed
to detect if significant statistical differences (𝑃 < 0.05)
between both groups were observed. A comparison between
right and left eye was previously done for monocular tests.
This analysis showed no significant differences between both
eyes (𝑃 > 0.05), so that right eye results were only used.
For those tests with significant statistical differences (𝑃 <
0.05), the diagnostic validity of the test was assessed bymeans
of standard analyses: ROC curves, sensitivity (S), specificity
(Sp), and positive and negative likelihood ratios (LR+, LR−)
[49, 67].
Considering that in this study the presence of the con-
dition is the large exophoria at near and moderate to severe
symptoms, S is the proportion of patients of EXO-MHVD
group who have a positive test result and Sp is the proportion
of people of NH-LVD group who have a negative test result.
LR is a measure [67] that allows for information about
the diagnostic test itself to be summarized. LR+ shows how
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much to increase the probability of the condition if the test is
positive, while the negative likelihood ratio (LR−) shows how
much to decrease it if the test is negative. General guidelines
suggest that an LR > 1 indicates an increased probability that
the condition is present, and an LR < 1 indicates a decreased
probability that the condition is present.
A receiver operator characteristic (ROC) curve [49] plots
the true positive rate (S) versus the false positive rate (1 − Sp)
over a range of cut-off values. It is considered that the best cut-
off point is at or near the “shoulder” of the ROC curve because
as the sensitivity is progressively increased there is little or
no loss in specificity until very high levels of sensitivity are
achieved.Thus, the overall accuracy of a test can be described
as the area under the ROC curve, so that the larger the area,
the better the test. If this area has a value of 1 it will indicate
the perfection of the test, as both values of S and Sp would be
1.
In order to analyze which tests had the better diagnostic
accuracy, for those tests which had obtained significant
statistical differences (𝑃 < 0.05), the area under the ROC
curve and the coordinates of the curve (the cut-off points for
each test) were examined. The choice of these cut-off points
wasmade bymeans of a balance between S and Sp.These cut-
offs are necessary to take into account the number of patients
who pass or fail each test.
Once considered the diagnostic validity of each test
separately, the same was carried out considering multiple
tests as serial testing strategy. This situation implies that all
tests must be present. For that, the order used was from the
greater to the less accurate test considering the area under
ROCcurve. First of all it was considered that the subject failed
the most accurate test. Secondly the subject failed the two
tests with better area. Next the three tests with the better area
and so on until taking into account all tests were analyzed.
Once the combinations of tests with the best results were
chosen, diagnostic validity was also performed using the
cut-off derived from the normative values of the scientific
literature.
All the statistical and epidemiologic analysis was per-
formed using the statistical software SPSS 15.0 for Windows
and the EPIDAT 3.1 program.
3. Results
Table 2 shows mean value and standard deviation for each
accommodative and binocular test for both group of patients.
Tests with statistically significant differences (𝑃 < 0.05) have
been highlighted. According to BAF results, it was noted that
all patients for EXO-MHVDGroup had difficulty in focusing
with positive lenses.
Figure 1 reveals ROC curves for each of the tests with
statistical significant differences. Table 3 shows the results of
the area under the ROC curve for each clinical sign ordered
from highest to lowest.The selected coordinates of each ROC
curve, which represent the cut-off points for every test, appear
in Table 4. Using these cut-off points, diagnostic validity was
obtained for each test by means of S, Sp and LR ratios values
Table 2: Comparison of samples between both groups of patients.
Test
NH-LVD group
(𝑁 = 33)
Average value ± SD
EXO-MHVD
group
(𝑁 = 33)
Average value ± SD
𝑃-value
AC/A 2.41/1 ± 1.31Δ/D 1.96 ± 0.84 Δ/D 0.25
AA 10.97 ± 1.71 D 11.04 ± 2.03D 0.83
MAF 12.86 ± 3.34 cpm 7.28 ± 5.29 cpm <0.001∗
BAF 10.82 ± 3.62 cpm 4.45 ± 4.14 cpm <0.001∗
MEM 0.61 ± 0.23D 0.34 ± 0.37D 0.002∗
NRA 2.30 ± 0.32D 2.07 ± 0.43D 0.02∗
PRA 3.56 ± 1.13D 4.23 ±1.54D 0.10
PFV blur 19.68 ± 6.11Δ 16.70 ± 6.46Δ 0.09
PFV break 25.64 ± 7.05Δ 22.85 ± 8.42Δ 0.10
PFV recovery 13.61 ± 6.35Δ 13.73 ± 7.24Δ 0.90
NPC break 2.93 ± 2.02 cm 7.00 ± 4.13 cm <0.001∗
NPC
recovery 7.41 ± 1.19 cm 11.07 ± 3.05 cm <0.001
∗
VF 15.91 ± 2.57 cpm 10.35 ± 6.16 cpm <0.001∗
Stereopsis 42.73 ± 9.45# 39.85 ± 9.23# 0.31
NH-LVD: normal heterophoria and low visual discomfort; EXO-MHVD:
large exophoria at near andmoderate or high visual discomfort; SD: standard
deviation, AC/A: ratio AC/A, AA: accommodative amplitude,MAF:monoc-
ular accommodative facility, MEM: monocular estimated method, NRA:
negative relative accommodation, PRA: positive relative accommodation,
BAF: binocular accommodative facility, VF: vergence facility, PFV: positive
fusional vergence, NPC: near point of convergence, Δ: prismatic diopter, D:
diopter, cpm: cycles per minute, (#): seconds of arch. (∗P < 0.05 indicates
statistically significant differences between both groups).
with their confidence intervals to 95%; results are also shown
in Table 4.
Table 5 shows the results of S, Sp, LR+, and LR− con-
sidering multiple tests as serial testing strategy. As can be
observed, the best results are obtained for the combination
of both tests of NPC (break and recovery) and BAF which
are those with the best diagnostic accuracy according to
their ROC curves. Thus, once these three clinical signs were
chosen and considering that the NPC has two responses,
break and recovery point, three possible situations were
considered. First, subjects failed the NPC break and BAF test
having difficulty in focusing with positive lenses. Secondly,
subjects failed NPC recovery with BAF. And thirdly, subjects
failed NPC break and recovery and the BAF test. Table 6
shows the diagnostic validity for these combinations using
the cut-off points obtained by means of ROC curves and also
considering the cut-off derived from the normative values of
the scientific literature for NPC break and recovery [6, 28, 29,
68] and BAF testing [61].
4. Discussion
Results of this research have shown that the tests related to
a near large exophoria having the better diagnostic accuracy
are the NPC and BAFwith difficulty in focusing with positive
lenses. In any case, it is necessary to consider that these results
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Figure 1: ROC curves for near point of convergence break and recovery, binocular accommodative facility, monocular accommodative
facility, vergence facility, monocular estimate method and negative relative accommodation.
Table 3: Area under the ROC curve for different tests.
Variable Area Confidence interval to 95 % 𝑃-value
Low limit Top limit
NPC recovery 0.929 0.855 1 <0.001
BAF 0.886 0.797 0.976 <0.001
NPC break 0.816 0.704 0.928 <0.001
MAF 0.814 0.704 0.925 <0.001
VF 0.787 0.672 0.901 <0.001
MEM 0.714 0.589 0.839 0.003
NRA 0.665 0.533 0.797 0.02
NPC: near point of convergence, BAF: binocular accommodative facility,
MAF: monocular accommodative facility, VF: vergence facility, MEM:
monocular estimate method, NRA: negative relative accommodation, P <
0.05: the obtained area differs statistically from the real value of 0.5.
may have limitations since the sample size is not too high.
These findings could change in a higher sample of patients,
in the sense that tests for which no statistical significant
differences were detected (𝑃 > 0.05) could have been with
a larger population.
Diagnostic validity considering cut-offs offered by ROC
curves shows that the best results of S and Sp are for the
NPC recovery with the cut-off of ≥8.25 cm. Similarly the
test of BAF at the cut-off of ≤8.25 cycles per minute (cpm)
achieves balanced values of S and Sp. Taking into account the
peculiarity of NPC as the NPC recovery cannot be obtained
without measuring previously the break value, it should be
logical to also consider this result. The NPC break with
the cut-off of ≥5.35 cm does not obtain a very high S but
considering its balance with the Sp it is the value that allows
a good Sp.
Results of likelihood ratios show that NPC recovery, BAF,
and NPC break are the tests with better diagnostic validity as
they have a good balance between S, Sp, LR+, and LR−. Other
tests as MAF obtain good results for positive likelihood.
However, the negative likelihood is poor and the sensitivity
is not very high. With these results, the selection of the NPC
(break and recovery) and BAF as signs associated to the
condition examined should be justified. Furthermore, these
three tests have an area under the ROC curve close to 1. The
fact that a test is more accurate when the area is larger would
also justify the election of these clinical signs.
When considering diagnostic validity of different com-
binations it can be observed that in all cases Sp reaches the
value of 1, changing S and LR values. The best results are
obtained for the combination of receded NPC recovery and
BAF test failing with positive lenses. Reading these results
implies that when both tests are used as serial testing strategy,
that is, when the patient fails the NPC recovery, then the
BAF is assessed and it fails having difficulty in focusing the
image with positive lenses; 77% of subjects of EXO-MHVD
group have a positive result. Furthermore, the SP achieved
means that all subjects of NH-LVD group obtain adequate
negative results as no one has a positive result in both tests.
When considering likelihood ratios, LR+ result indicate that
for EXO-MHVD group, there is a very high likelihood (a
value which tends to infinity) of having a positive result (NPC
and BAF failed) compared with the NH-LVD group. LR−
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Table 4: Diagnostic validity for each test using cut-offs obtained with ROC curves.
Test Cut-off with ROC curve Sensitivity(CI 95%)
Specificity
(CI 95%)
LR+
(CI 95%)
LR−
(CI 95%)
NPC recovery ≥8.25 cm 0.85(0.69–1)
0.82
(0.61–1)
4.79
(1.69–14)
0.19
(0.08–0.48)
BAF ≤8.25 cpm 0.88(0.75–1)
0.79
(0.63–0.94)
4.14
(2.12–8.09)
0.15
(0.06–0.39)
NPC break ≥5.35 cm 0.73(0.56–0.89)
0.91
(0.80–1)
8.00
(2.67–24)
0.30
(0.17–0.53)
MAF ≤8.25 cpm 0.70(0.52–0.87)
0.94
(0.84–1)
12.00
(2.95–45)
0.32
(0.19–0.55)
VF ≤14.75 cpm 0.70(0.52–0.87)
0.70
(0.52–0.87)
2.30
(1.31–4.04)
0.25
(0.25–0.76)
MEM ≤0.63D 0.73(0.56–0.89)
0.55
(0.36–0.73)
1.60
(1.04–2.46)
0.50
(0.26–0.95)
NRA ≤2.38D 0.76(0.60–0.92)
0.52
(0.33–0.70)
2.30
(1.31–4.04)
0.43
(0.25–0.76)
LR+: positive likelihood ratio, LR−: negative likelihood ratio, CI: confidence interval, NPC: near point of convergence, BAF: binocular accommodative facility,
MAF: monocular accommodative facility, VF: vergence facility, MEM: monocular estimated method, NRA: negative relative accommodation, cpm: cycles per
minute, D: diopter.
Table 5: Diagnostic validity for different test combinations using cut-offs derived from ROC analysis.
Tests Cut-off used Sensitivity(CI 95%)
Specificity
(CI 95%)
LR+
(CI 95%)
LR−
(CI 95%)
NPC recovery NPC recovery ≥ 8.25 cm 0.85(0.69–1)
0.82
(0.61–1)
4.79
(1.69–14)
0.19
(0.08–0.48)
NPC recovery + BAF NPC recovery ≥ 8.25 cmBAF ≤ 8.25 cpm
0.77
(0.59–0.95)
1
(0.97–1) NA
0.23
(0.13–0.49)
NPC recovery + BAF +
NPC break
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
NPC break ≥ 5.35 cm
0.73
(0.54–0.92)
1
(0.97–1) NA
0.27
(0.15–0.53)
NPC recovery + BAF
+NPC break + MAF
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
NPC break ≥ 5.35 cm
MAF ≤ 8.25 cpm
0.58
(0.37–0.79)
1
(0.97–1) NA
0.42
(0.28–0.68)
NPC recovery + BAF +
NPC break + MAF + VF
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
NPC break ≥ 5.35 cm
MAF ≤ 8.25 cpm
VF ≤ 14.75 cpm
0.42
(0.21–0.63)
1
(0.97–1) NA
0.58
(0.42–0.82)
NPC recovery + BAF
+NPC break + MAF + VF
+ MEM
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
NPC break ≥ 5.35 cm
MAF ≤ 8.25 cpm
VF ≤ 14.75 cpm
MEM ≤ 0.63D
0.31
(0.11–0.50)
1
(0.97–1) NA
0.69
(0.54–0.92)
NPC recovery + BAF
+NPC break + MAF +VF +
MEM + NRA
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
NPC break ≥ 5.35 cm
MAF ≤ 8.25 cpm
VF ≤ 14.75 cpm
MEM ≤ 0.63D
NRA ≤ 2.38D
0.27
(0.08–0.46)
1
(0.97–1) NA
0.73
(0.58–0.95)
LR+: positive likelihood ratio, LR−: negative likelihood ratio, CI: confidence interval, NPC: near point of convergence, BAF: binocular accommodative facility,
MAF: monocular accommodative facility, VF: vergence facility, MEM: monocular estimated method, NRA: negative relative accommodation, cpm: cycles per
minute, D: diopter. NA: not applicable as the value tends to infinity.
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Table 6: Diagnostic validity considering multiple tests as serial testing strategy using cut-offs derived from ROC analysis and scientific
literature.
Tests Cut-offs used Sensitivity(CI 95%)
Specificity
(CI 95%)
LR+
(CI 95%)
LR−
(CI 95%)
NPC break + BAF
ROC
NPC break ≥ 5.35 cm
BAF ≤ 8.25 cpm
0.67
(0.49–0.84)
1
(0.98–1) NA
0.33
(0.21–0.55)
NPC recovery + BAF
ROC
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
0.77
(0.59–0.95)
1
(0.97–1) NA
0.23
(0.13–0.49)
NPC break + NPC recovery
+ BAF
ROC
NPC break ≥ 5.35 cm
NPC recovery ≥ 8.25 cm
BAF ≤ 8.25 cpm
0.73
(0.54–0.92)
1
(0.97–1) NA
0.27
(0.15–0.53)
NPC break + BAF
Literature
NPC break ≥ 7.50 cm
BAF < 3 cpm
0.21
(0.06–0.37)
1
(0.98–1) NA
0.79
(0.66–0.95)
NPC recovery + BAF
Literature
NPC recovery ≥ 10.50 cm
BAF < 3 cpm
0.19
(0.02–0.36)
1
(0.97–1) NA
0.81
(0.67–1)
NPC break + NPC recovery
+ BAF
Literature
NPC break ≥ 7.50 cm
NPC recovery ≥ 10.50 cm
BAF < 3 cpm
0.19
(0.02–0.36)
1
(0.97–1) NA
0.81
(0.67–1)
LR+: positive likelihood ratio, LR−: negative likelihood ratio, CI: confidence interval, NPC: near point of convergence, BAF: binocular accommodative facility,
cpm: cycles per minute. NA: not applicable as the value tends to infinity.
of 0.23 indicates that for NH-LVD group, the likelihood of
having a negative result (NPC and BAF normal) is 4.3 times
greater than for EXO-NHVD group. When the NPC break is
also considered (three clinical signs) results are also adequate.
However, when assuming four clinical signs (adding MAF
test), diagnostic validity results are poor. S and Sp values
diminish and LR− of 0.42 indicates that for NH-LVD group,
the likelihood of having a negative result is only 2.4 times
greater than for EXO-NHVD group. This situation would
justify the selection of NPC (recovery and break) and BAF
testing not only for being the tests with the best area under
the ROC curve but also because considering the combination
of these three clinical signs adequate S, Sp, and LR ratios are
obtained. In addition, results of this study also suggest that
using the cut-off of ROC analysis, diagnostic validity is better
than using the cut-off of scientific literature.
According to the clinical signs associated with a large
near exophoria, results of this study only partially coincide
with the usual clinical signs associated with CI condition.
[1, 5–14, 19–30, 69–78]. The finding of NPC as a clinical sign
associated with the presence of a large near exophoria agrees
with its use when diagnosing CI although the cut-off values
differ between authors. The studies of Borsting et al. [6],
Rouse et al. [28, 29], and Gallaway et al. [76] use a cut-off
value of ≥7.5 cm for a receded NPC break. Several researches
consider 6 cm to establish a receded NPC for CI [1, 7, 8, 11–
14, 22, 30, 74]. However, others have used cut-offs of 10 cm [9,
20, 21, 24, 25, 69, 72, 73, 77] and some authors have considered
20 cm [26]. As it can be observed there aremore studieswhich
use the cut-offs of 6 cm and 10 cm even when only studies of
adult population are considered [7, 9, 12, 24, 69, 73, 74, 76].
For NPC recovery, there are also differences between authors.
Both studies of Rouse et al. [28, 29] use a cut-off value forNPC
recovery ≥ 10.5 cm. Birnbaum et al. [69] use a value of >15 cm
while those researches of Scheiman et al. [20] and Garc´ıa et
al. [9] use the value of >17.5 cm. As it can be observed there
are fewer authors who refer to NPC recovery for diagnosing
CI. And even the authors who do use this clinical sign specify
that the subject may fail the NPC break or recovery.
It is clear that the cut-off value obtained in this study
with ROC analysis for NPC break (≥5.35 cm) is lower than
those used by other authors when CI is considered. However,
it is more similar to those values found by other authors
who have analyzed the NPC normative values. This is the
case of the study of Scheiman et al. [65], in which the
authors have found cut-offs of 5 cm for NPC break in an adult
population with similar ages to those of this investigation,
that is, a nonpresbyopic population. Similarly, Maples and
Hoenes [79] recommend using an NPC break of ≥5 cm as a
criterion to differ between asymptomatic and symptomatic
subjects associated with the diagnosis of a CI. Nevertheless
it is necessary to take into account that the authors [79]
analyzed a sample of children with ages between 5 and 10
years and therefore not comparable with the adult population
examined in our study.
These comparisons cannot be established with other
studies when considering the BAF test. Unlike what happens
with the receded NPC, few studies explore BAF testing with
difficulty focusing with positive lenses when analyzing CI,
and when considering, authors mention it as a complemen-
tary sign which is not necessary to be present to diagnose
the condition. This is the case of the studies of Lara et al.
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[24], Scheiman et al. [20], Garc´ıa et al. [9], and Shin et al.
[30]. The difficulty on BAF testing with plus lenses should
be related to low PFV finding, which has shown a frequent
clinical sign associated with CI [48]. However this study does
not show differences between both groups of adult patients so
that the reduced PFV cannot be associated with a large near
exophoria. This finding could be explained due to the small
sample which may diminish the statistical power of results.
A larger sample could have shown statistical differences
between groups. Other explanation should be related to the
fact that PFV measurements have shown low repeatability
[80]. Anyway, the fact that BAF testing with difficulty in
positive lenses has good diagnostic validity should indicate
that subjects with a large exophoria at near may have altered
the phasic component of the accommodative controller and
not only exhibit a rapid adaptation of accommodation, as it
has been stated by several authors [81].
In summary, this study shows that for subjects with a
large near exophoria and moderate to severe symptoms,
the accommodative and binocular tests that show a higher
diagnostic accuracy are NPC and BAF. Then, when symp-
tomatic adults present a large near exophoria and the clinician
suspects a CI condition, it should be considered to measure
theNPC. If the result is failed at break, recovery or both values
the clinician should consider assessing the BAF testing with
±2.00D.
Although results of this study are based on a limited
number of subjects and should be confirmed in forthcoming
studies, they have important clinical implications. This is an
investigation in which epidemiological tools have been used
to identify which clinical signs are associatedwith a large near
exophoria by means of diagnostic validity measurements.
Accordingly, these findings may add evidence to support the
importance of using different clinical tests in the assessment
of binocular function in clinical settings.
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